OFG
ABBV icon

Oxford Financial Group’s AbbVie ABBV Stock Holding History

Oxford Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Sell
2,760
-1,957
-41% -$421K 0.04% 137
2026
Q1 		$1.03M Sell
4,717
-480
-9% -$106K 0.06% 99
2025
Q4 		$1.19M Buy
5,197
+77
+2% +$17.5K 0.07% 78
2025
Q3 		$1.19M Buy
5,120
+299
+6% +$60.9K 0.07% 81
2025
Q2 		$895K Sell
4,821
-645
-12% -$120K 0.05% 90
2025
Q1 		$1.15M Sell
5,466
-384
-7% -$74.7K 0.08% 72
2024
Q4 		$1.04M Sell
5,850
-62
-1% -$11.4K 0.07% 93
2024
Q3 		$1.17M Sell
5,912
-1,003
-15% -$187K 0.07% 82
2024
Q2 		$1.19M Buy
6,915
+1,317
+24% +$218K 0.08% 81
2024
Q1 		$1.02M Buy
5,598
+176
+3% +$30.3K 0.07% 80
2023
Q4 		$840K Buy
5,422
+175
+3% +$25.5K 0.06% 96
2023
Q3 		$782K Sell
5,247
-298
-5% -$43.7K 0.07% 93
2023
Q2 		$747K Buy
5,545
+2,669
+93% +$391K 0.07% 96
2023
Q1 		$458K Buy
2,876
+204
+8% +$31.2K 0.05% 119
2022
Q4 		$432K Buy
+2,672
New +$410K 0.05% 124
2022
Q3 		– Sell
-2,505
Closed -$384K – 240
2022
Q2 		$384K Buy
2,505
+96
+4% +$14.7K 0.06% 127
2022
Q1 		$391K Sell
2,409
-31
-1% -$4.5K 0.05% 133
2021
Q4 		$330K Buy
2,440
+179
+8% +$21.1K 0.04% 156
2021
Q3 		$244K Sell
2,261
-1,946
-46% -$222K 0.03% 163
2021
Q2 		$474K Sell
4,207
-910
-18% -$102K 0.06% 114
2021
Q1 		$554K Sell
5,117
-168
-3% -$18K 0.08% 102
2020
Q4 		$566K Buy
5,285
+153
+3% +$14.7K 0.08% 94
2020
Q3 		$450K Buy
5,132
+25
+0.5% +$2.35K 0.07% 97
2020
Q2 		$501K Sell
5,107
-13
-0.3% -$1.15K 0.09% 95
2020
Q1 		$390K Buy
+5,120
New +$436K 0.08% 100

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Oxford Financial Group's ABBV Position: Q2 2026 in Review

Oxford Financial Group reduced its AbbVie (ABBV) stake by 41% in Q2 2026, selling an estimated $421K and leaving 2,760 shares worth $695K. The position accounts for 0.04% of the portfolio, ranked #137.

Oxford Financial Group first reported a position in ABBV in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.19M in Q4 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Oxford Financial Group held 2,760 shares of AbbVie worth $695K as of Q2 2026.
  • Oxford Financial Group sold 1,957 AbbVie shares in Q2 2026, an estimated $421K.
  • AbbVie made up 0.04% of Oxford Financial Group's portfolio in Q2 2026, its #137 holding.
  • Oxford Financial Group first reported a position in AbbVie in Q1 2020 and has held it in 25 quarters since.
  • Oxford Financial Group's AbbVie position peaked at $1.19M in Q4 2025.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Oxford Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.